Similar articles

• Initial strategies for integrating buprenorphine into HIV care settings in the United States.

  Sullivan LE, Bruce RD, Haltiwanger D, Lucas GM, Eldred L, Finkelstein R, Fiellin DA. Sullivan LE, et al. Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S191-6. doi: 10.1086/508183. Clin Infect Dis. 2006. PMID: 17109306 Review.
• Overcoming policy and financing barriers to integrated buprenorphine and HIV primary care.

  Schackman BR, Merrill JO, McCarty D, Levi J, Lubinski C. Schackman BR, et al. Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S247-53. doi: 10.1086/508190. Clin Infect Dis. 2006. PMID: 17109311 Review.
• Buprenorphine replacement therapy for adolescents with opioid dependence: early experience from a children's hospital-based outpatient treatment program.

  Levy S, Vaughan BL, Angulo M, Knight JR. Levy S, et al. J Adolesc Health. 2007 May;40(5):477-82. doi: 10.1016/j.jadohealth.2006.11.142. Epub 2007 Mar 9. J Adolesc Health. 2007. PMID: 17448411
• Opioid addiction and incarceration: an overview.

  Schwartz RP, McKenzie M, Rich JD. Schwartz RP, et al. Med Health R I. 2007 May;90(5):157-8. Med Health R I. 2007. PMID: 17557660 Review. No abstract available.
• Treatment of opiate dependence in hands of primary care providers.

  [No authors listed] [No authors listed] Public Health Rep. 2003 Jan-Feb;118(1):76. Public Health Rep. 2003. PMID: 12622131 Free PMC article. No abstract available.